Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway
Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier
Molecular Psychiatry (2018) Vol. 24, Iss. 5, pp. 643-652
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases
Yao Yao, Xiaoyu Cai, Fujia Ren, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 153
Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway
Alexandre Vallée
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2810-2810
Open Access | Times Cited: 87
TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts
Alexandre Vallée, Yves Lecarpentier
Cell & Bioscience (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 141
Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Cells (2019) Vol. 8, Iss. 7, pp. 726-726
Open Access | Times Cited: 82
Parkinson’s Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway
Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier
Cells (2021) Vol. 10, Iss. 2, pp. 230-230
Open Access | Times Cited: 51
Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 41
Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism
Rishabh Khera, Sidharth Mehan, Sonalika Bhalla, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 889-889
Open Access | Times Cited: 38
Potential role of cannabidiol in Parkinson’s disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation
Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier
Aging (2021) Vol. 13, Iss. 7, pp. 10796-10813
Open Access | Times Cited: 31
Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3798-3798
Open Access | Times Cited: 28
Probiotics and prebiotics alleviate behavioral deficits, inflammatory response, and gut dysbiosis in prenatal VPA-induced rodent model of autism
Emre Adıgüzel, Betül Çiçek, Gökhan Ünal, et al.
Physiology & Behavior (2022) Vol. 256, pp. 113961-113961
Closed Access | Times Cited: 20
Plasma vinculin, β-catenin, E-cadherin levels in children with autism spectrum disorder
Havvanur Eroğlu Doğan, Ümit Işık, Halil İbrahim Büyükbayram
International Journal of Developmental Disabilities (2025), pp. 1-8
Closed Access
Pioglitazone, an agonist of PPARγ, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression
Takashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109356-109356
Open Access | Times Cited: 33
Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT/β-catenin pathway and PPARγ
Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier
Journal of Molecular and Cellular Cardiology (2019) Vol. 133, pp. 36-46
Open Access | Times Cited: 32
Phytochemicals: Potential Therapeutic Modulators of Radiation Induced Signaling Pathways
Bimal Prasad Jit, Biswajita Pradhan, Rutumbara Dash, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 49-49
Open Access | Times Cited: 27
Serum claudin-5, claudin-11, occludin, vinculin, paxillin, and beta-catenin levels in preschool children with autism spectrum disorder
Ayhan Bi̇lgi̇ç, Hurşit Ferahkaya, Hülya Karagöz, et al.
Nordic Journal of Psychiatry (2023) Vol. 77, Iss. 5, pp. 506-511
Closed Access | Times Cited: 10
Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists
Jeremy P. McAleer
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 10
Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets
Asmita Deka Dey, Ashi Mannan, Sonia Dhiman, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1491-1516
Closed Access | Times Cited: 3
PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model
Takashi Higuchi, Jun Yamamoto, Norihiko Sugisawa, et al.
Cancer Genomics & Proteomics (2019) Vol. 17, Iss. 1, pp. 35-40
Open Access | Times Cited: 29
miR-4721, Induced by EBV-miR-BART22, Targets GSK3β to Enhance the Tumorigenic Capacity of NPC through the WNT/β-catenin Pathway
Zibo Tang, WeiFeng Chen, Yan Xu, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 22, pp. 557-571
Open Access | Times Cited: 23
Osteosarcoma Patient-derived Orthotopic Xenograft (PDOX) Models Used to Identify Novel and Effective Therapeutics: A Review
Takashi Higuchi, Kentaro Igarashi, Norio Yamamoto, et al.
Anticancer Research (2021) Vol. 41, Iss. 12, pp. 5865-5871
Open Access | Times Cited: 19
m6A Methyltransferase METTL3 Reduces Hippocampal Neuron Apoptosis in a Mouse Model of Autism Through the MALAT1/SFRP2/Wnt/β-catenin Axis
Yue Ming, Zhihui Deng, Xianhua Tian, et al.
Psychiatry Investigation (2022) Vol. 19, Iss. 10, pp. 771-787
Open Access | Times Cited: 14
Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 230-248
Closed Access | Times Cited: 16
A redox-responsive nanosystem to suppress chemoresistant lung cancer through targeting STAT3
Qiyi Feng, Jie Chen, Jinxing Huang, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 349-360
Closed Access | Times Cited: 6
PPARγ Agonists: Emergent Therapy in Endometriosis
Alexandre Vallée, Jean-Noël Vallée, A. Le Blanche, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 543-543
Open Access | Times Cited: 13
The Changes of Amygdala Transcriptome in Autism Rat Model After Arginine Vasopressin Treatment
Bo Zhou, Xiaoli Zheng, Yunhua Chen, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top